Buda Juice Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $113.5M
- Price
- $8.89
- % Change (Daily % change from the live per-ticker quote feed.)
- -3.68%
- Volume
- 2.2K
About
Buda Juice, LLC produces and sells cold-pressed, organic juices. The company provides USDA certified organic, cold-pressed juices made from fruits and vegetables, available in glass bottles. Its offerings include juice cleanses ranging from one to five days, ginger and turmeric shots sold in bulk packs, citrus-based juices under the Buda Zen brand, organic soups, and plant-based milks. All products are kept refrigerated from production to sale to maintain freshness. The company serves wholesale clients. The company was founded in 2013 and is based in Dallas, Texas.
Quick stats
Shares outstanding12.6M
Computed float3.3M
Float / shares26.0%
Key info
SectorConsumer Defensive
IndustryBeverages - Non-Alcoholic
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0002079720
Websitehttps://www.budajuice.com
AI Summary
AI-generated1/14
majorbullishearnings
Buda Juice Reports Second Quarter 2026 Financial Results
Buda Juice reported Q2 2026 revenue of $4.5 million, up 26.4% year-over-year, driven by distribution expansion into 246 Walmart locations and a new dressings acquisition.
Gross margin compressed to 36.6% from 46.7% due to temporary factors including third-party co-packing and high lime costs, while net income declined to $0.5 million.
The company holds $18.8 million in cash with no debt and reported preliminary Q3 sales growth of over 40%, signaling strong momentum despite near-term margin headwinds.
Red flags
- Gross margin declined 1,010 basis points to 36.6%
- Free cash flow was negative $(0.8) million, primarily due to a one-time increase in accounts receivable
- Operating expenses increased to 26.8% of revenue from 14.7% due to public company costs and stock-based compensation